
The treatment of hypertension had extended millions of lives since the mid-20th century when hypotensive medications were few. Since then, therapeutic options have expanded to include multiple classes and scores of individual antihypertensive agents, diuretics, beta-blockers, renin-angiotensin system blockers (angiotensin-converting–enzyme inhibitors and angiotensin II receptor blockers, foremost), calcium-channel blockers, alpha-blockers, α-2-receptor agonists, combined alpha- and beta-blockers, vasodilators, and centrally acting compounds. Some of the approved antihypertensives remain in use, including chlorthalidone. This thiazide-like sulfonamide-derived diuretic was first approved by the Food and Drug Administration (FDA) in 1960.
Like
Save
Share